Literature DB >> 18626979

Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study.

Taxiarchis Felekis1, Konstantinos Katsanos, Margarita Kitsanou, Nikolaos Trakos, Vasileios Theopistos, Dimitrios Christodoulou, Ioannis Asproudis, Epameinondas V Tsianos.   

Abstract

BACKGROUND: The frequency and spectrum of ophthalmologic manifestations in patients with inflammatory bowel disease (IBD) has been reported to vary among studies; however, rare and silent manifestations have not been extensively studied.
METHODS: This was a prospective study of 60 patients diagnosed with IBD who underwent full ophthalmologic examination, including visual acuity, slit lamp examination of the anterior segments, intraocular pressure, and fundus examination accompanied by color photography. Thirty-seven (61,7%) patients were diagnosed with ulcerative colitis (UC) and 23 (38,3%) with Crohn's disease (CD). Data from 276 control individuals were used for the determination of the prevalence of dry eye in our area.
RESULTS: Ophthalmologic manifestations were diagnosed in 26 (43%) patients (14 UC, 12 CD; 12 males and 14 females). Conjunctivitis was diagnosed in 1 patient (CD), episcleritis in 2 patients (UC), and iridocyclitis in 3 (CD). Fundus examination showed 1 patient (CD) with unilateral choroiditis, 1 (UC) with retinal vasculitis, and 1 (CD) with optic neuritis. Retinal pigment epithelium disturbances (RPED) were present in 3 patients (1 CD, 2 UC) and 2 had serous retinal detachment. In total, 13/60 patients (22%) had dry eye compared with the 11% prevalence in controls. Eight patients developed glucocorticosteroid-induced cataracts, 2 of them treated surgically.
CONCLUSIONS: This study demonstrated the prevalence of the spectrum of ophthalmologic manifestations in the IBD population, including some rare and silent findings that may merit consideration and early intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18626979     DOI: 10.1002/ibd.20584

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  31 in total

1.  Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits.

Authors:  Sasha Taleban; Dalin Li; Stephan R Targan; Andrew Ippoliti; Steven R Brant; Judy H Cho; Richard H Duerr; John D Rioux; Mark S Silverberg; Eric A Vasiliauskas; Jerome I Rotter; Talin Haritunians; David Q Shih; Marla Dubinsky; Gil Y Melmed; Dermot P B McGovern
Journal:  J Crohns Colitis       Date:  2015-10-08       Impact factor: 9.071

2.  Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.

Authors:  Konstantinos Karmiris; Anastasios Avgerinos; Aikaterini Tavernaraki; Christos Zeglinas; Pantelis Karatzas; Theodoros Koukouratos; Konstantinos A Oikonomou; Athanasios Kostas; Evanthia Zampeli; Vasileios Papadopoulos; Angeliki Theodoropoulou; Nikos Viazis; Dimitrios Polymeros; Spyridon Michopoulos; Giorgos Bamias; Andreas Kapsoritakis; Dimitrios G Karamanolis; Gerassimos J Mantzaris; Charalampos Tzathas; Ioannis E Koutroubakis
Journal:  J Crohns Colitis       Date:  2015-12-30       Impact factor: 9.071

3.  Decreased retinal blood flow in experimental colitis; improvement by eye drop administration of losartan.

Authors:  Megan N Watts; Randa S Eshaq; Patsy R Carter; Norman R Harris
Journal:  Exp Eye Res       Date:  2013-07-02       Impact factor: 3.467

4.  Orbital pseudotumour as a presentation of paediatric ulcerative colitis.

Authors:  Justin Hung Tiong Tan; Hui Ping Chu; Lena Das; Thaschawee Arkachaisri
Journal:  Singapore Med J       Date:  2014-10       Impact factor: 1.858

Review 5.  Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?

Authors:  Fernando Tavarela Veloso
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

6.  Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease.

Authors:  Benjamin Alexandre; Yves Vandermeeren; Olivier Dewit; Tom Moreels; Nanne de Boer; Anjan Dhar; Chris Ziady; Ariella Bar-Gil Shitrit; Flavio Steinwurz; Njegica Jojic; Giuseppe Costantino; Benoit Bihin; Jean-François Rahier; Konstantinos H Katsanos
Journal:  J Crohns Colitis       Date:  2016-01-12       Impact factor: 9.071

7.  Smoking increases the risk of extraintestinal manifestations in Crohn's disease.

Authors:  Claudia Ott; Angela Takses; Florian Obermeier; Elisabeth Schnoy; Martina Müller
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

8.  Retinal vasculitis: a novel paradoxical effect of anti-TNFα?

Authors:  Kaouther Ben Abdelghani; Maroua Slouma; Wady Ben Jalel; Leith Zakraoui
Journal:  BMJ Case Rep       Date:  2014-08-20

Review 9.  Ocular manifestations in celiac disease: an overview.

Authors:  Fotios S Fousekis; Andreas Katsanos; Konstantinos H Katsanos; Dimitrios K Christodoulou
Journal:  Int Ophthalmol       Date:  2020-01-08       Impact factor: 2.031

10.  Differential diagnoses to MS: experiences from an optic neuritis clinic.

Authors:  Henrik Horwitz; Tina Friis; Signe Modvig; Hanne Roed; Anna Tsakiri; Bjarne Laursen; Jette Lautrup Frederiksen
Journal:  J Neurol       Date:  2013-10-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.